Nicotine use disorders, which are typically acquired through tobacco smoking, are a global problem and a leading cause of preventable deaths. Unfortunately, the available therapies intended for tobacco smoking cessation have varying efficacy among smokers in addition to some adverse effects observed. These factors, alongside the cost of such therapies deemed as a financial burden by some, contribute to the failure to meet patients" needs. This necessitates the many studies being conducted on the possible use of natural products in the treatment of nicotine use disorders to address such issues. Therefore, this review aims to discuss published data documenting the effects of plant extracts and bioactive compounds on nicotine-induced reactions and nicotine use disorders by looking into the different effects, possible mechanisms, and the putative targets of these selected natural products. A total of 21 natural products and bioactive compounds were obtained from searches across PubMed, Ovid Medline and Scopus databases which comprised of studies performed in vitro and in vivo as well as human trials. These data suggest that these natural products may have the potential to be utilized to treat nicotine use disorders. Undoubtedly, more detailed studies are still required to resolve conflicting or inconclusive outcomes from these investigations before clinical use is warranted.